NCT00458718View on ClinicalTrials.gov

Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch

PHASE3CompletedINTERVENTIONAL

Enrollment

755

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Smoking Cessation

Interventions

DRUG

rimonabant (SR141716)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00458718 - Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch | Biotech Hunter | Biotech Hunter